IntegraDose Vasopressin 2 Units/2mL Recall: Subpotent Drug Risk
IntegraDose recalls Vasopressin 2 Units/2mL in 0.9% Sodium Chloride due to subpotent drug risk. Affected lots have specific NDC and expiration dates. Contact for remedy.
Lower-risk recall
Subpotent Drug
Contact the company
What happened, in plain English
IntegraDose is recalling Vasopressin 2 Units/2mL in 0.9% Sodium Chloride because it may be subpotent. This means the medication might not work as intended, which could affect treatment effectiveness. Read more at govinfonow.com/recall/31300-integradose-vasopressin-2-units-2ml-recall-subpotent-drug-risk.
Source Summary by GovInfoNow · govinfonow.com/recall/31300-integradose-vasopressin-2-units-2ml-recall-subpotent-drug-risk · Updated August 17, 2026 · FDA enforcement record: FDA #D-0593-2026
Cite this page
“IntegraDose Vasopressin 2 Units/2mL Recall: Subpotent Drug Risk.” GovInfoNow, updated August 17, 2026. https://govinfonow.com/recall/31300-integradose-vasopressin-2-units-2ml-recall-subpotent-drug-risk. Based on FDA recall #D-0593-2026 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0593-2026%22&limit=1).
Why it’s dangerous
Subpotent drugs have reduced effectiveness compared to the intended strength. This could lead to inadequate treatment if the medication doesn't work as prescribed.
Who’s affected
Patients using this specific Vasopressin product for medical treatment. Healthcare providers who administered the medication are most at risk.
How to tell if you have this one
Check for the NDC number 71139-0190-1 on the product label. Look for lot numbers 20260327VAS-3 (expires 05/26/2026) or 20260320VAS-3 (expires 05/19/2026).
- Brand
IntegraDose- Category
Drug
What to do — step by step
Check Product Details
Verify the NDC number 71139-0190-1 and lot numbers 20260327VAS-3 or 20260320VAS-3 on the product label.
Where it went and when
Where it was distributed
Distributed nationwide.
FDA distribution: “U.S.A. Nationwide” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA published this recall 37 days after the firm started it.
- Firm started the recall
- FDA classified it Class II
- Published in FDA’s Enforcement Report
Dates from the agency record only; steps without a date are left out.
Questions people ask
Is this product safe to use?
The recall states it may be subpotent, meaning it could be less effective than intended. Do not use if you have the specific lot numbers listed.
Similar recalls
Latest drug recalls
Keep exploring
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #D-0593-2026 (May 18, 2026) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0593-2026 to see it in context.
- Plain-language summary written by qwen3:4b on August 17, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.